EXHIBIT 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Gain Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit(2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | Rule 457(c) | 744,026 | $ | 2.445 | $ | 1,819,180.77 | 0.00014760 | $ | 268.51 | |||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share, issuable upon exercise of Pre-funded Warrants (3) | Rule 457(c) | 1,756,062 | $ | 2.445 | $ | 4,763,318.18 | 0.00014760 | 703.07 | ||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share, issuable upon the exercise of Warrants (4) | Rule 457(c) | 2,500,088 | $ | 2.445 | $ | 4,293,659.39 | 0.00014760 | 633.74 | ||||||||||||||||
| Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||||
| Carry Forward Securities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||||
| Total Offering Amounts | $ | 1,605.32 | ||||||||||||||||||||||||
| Total Fees Previously Paid | $ | 0 | ||||||||||||||||||||||||
| Net Fee Due | $ | 1,605.32 | ||||||||||||||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate number of additional common stock, par value $0.0001 per share (the “Common Stock”) of Gain Therapeutics, Inc. (the “Registrant”) as may be issued or issuable because of stock splits, stock dividends stock distributions, and similar transactions. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act based on a per share price of the average of the high $2.55 and low $2.34 reported sales prices of the Registrant’s Common Stock on the Nasdaq Stock Market LLC on December 18, 2023, which date is within five (5) business days of the filing of the registration statement by the Registrant for the registration of the securities listed in the table above. |
| (3) | Represents shares of Common Stock issuable upon the exercise of Pre-Funded Warrants to purchase Common Stock at a nominal exercise price of $0.0001 per share, subject to adjustment in accordance with the terms of the Pre-Funded Warrant issued by the Registrant on November 23, 2023. |
| (4) | Represents shares of Common Stock issuable upon the exercise of warrants to purchase Common Stock at an exercise price of $2.75 per share issued by the Registrant on November 23, 2023. |
